Shandong Xinhua Pharmaceutical Co Ltd (000756) — Net Asset Quality Index
Shandong Xinhua Pharmaceutical Co Ltd (000756) has a Net Asset Quality Index of 58.1% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥9.24 Billion minus total liabilities of CN¥3.87 Billion yields net assets of CN¥5.36 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Shandong Xinhua Pharmaceutical Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shandong Xinhua Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2015–2024)
This chart shows how Shandong Xinhua Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the index stands at 58.1%, representing net assets of CN¥5.36 Billion against total assets of CN¥9.24 Billion CNY. Explore cash flow conversion of Shandong Xinhua Pharmaceutical Co Ltd to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
The table below presents the year-by-year Net Asset Quality Index for Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Shandong Xinhua Pharmaceutical Co Ltd market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 57.8% | CN¥5.22 Billion | CN¥9.02 Billion | CN¥3.80 Billion | ▲ +0.2 pp |
| 2023 | 57.6% | CN¥4.78 Billion | CN¥8.29 Billion | CN¥3.51 Billion | ▲ +5.0 pp |
| 2022 | 52.6% | CN¥4.35 Billion | CN¥8.27 Billion | CN¥3.92 Billion | ▲ +2.8 pp |
| 2021 | 49.8% | CN¥3.65 Billion | CN¥7.33 Billion | CN¥3.68 Billion | ▲ +2.0 pp |
| 2020 | 47.8% | CN¥3.39 Billion | CN¥7.09 Billion | CN¥3.70 Billion | ▼ -0.5 pp |
| 2019 | 48.3% | CN¥3.11 Billion | CN¥6.44 Billion | CN¥3.33 Billion | ▲ +1.1 pp |
| 2018 | 47.3% | CN¥2.80 Billion | CN¥5.92 Billion | CN¥3.12 Billion | ▼ -1.6 pp |
| 2017 | 48.9% | CN¥2.58 Billion | CN¥5.27 Billion | CN¥2.69 Billion | ▲ +4.9 pp |
| 2016 | 44.0% | CN¥2.08 Billion | CN¥4.72 Billion | CN¥2.64 Billion | ▼ -0.1 pp |
| 2015 | 44.2% | CN¥1.98 Billion | CN¥4.49 Billion | CN¥2.51 Billion | — |